FDA Investigator Christopher T Middendorf

Christopher T Middendorf has inspections in 11 countries as of 09 Nov 2023. Christopher T Middendorf has collaborated with a combinined 7405 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
193
Last Inspection Date:
09 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, China, Italy, Germany, Norway, United Kingdom of Great Britain and Northern Ireland, Canada, France, Lithuania, Switzerland, Ireland
Co-Investigator(s):
A Williams, Ademola O Daramola, Alan Escalona, Alan P Kurtzberg, Alanna Lmussawwir Bias, Alberto A Viciedo, Alec M O'neal, Alexander M Kay, Alice S Tsao, Allison C Hunter, Allison M Scheck, Almaris N Alonso, Amanda M Dunneback, Amir Alavi, Amy M Cramer, Ana P Barido, Anastasia G Lolas, Andrew I Carr, Andrew J Barrowcliff, Andrew J Barroweliff, Andrew J Lang, Andrew M Kupper, Andria L Kuhlman, Angela E Glenn, Angelica M Hernandez, Anissa C Kelley, Anita R Michael, Ann L Demarco, Anna M Brannen, Annemarie Bodnar, Annemarie Kleiza, Arie R Dyk, Ariel Cruz Figueroa, Arlene M Badillo, Arsen Karapetyan, Bailey A Uetrecht, Benjamin D Shuler, Benjamin J Dastoli, Benjamin P Stewart, Bethany L Subel, Bo Chi, PhD, Brenda C Hamilton, Brenda W Uratani, PhD, Brett R Havranek, Brian D Nicholson, Brian D Rogers, Brian J Ryan, Bryan J Love, Bryan M Gamble, Bryce A Hammer, Byeongtaek Oh, Camerson E Moore, Carl A Huffman, III, Carl Lee, Carla A Norris, Carolyn E Barney, Caryn M Mcnab, Cassandra L Winters, Catherine J Laufmann, Charles C Conn, III, Charles Cconn Lii, Charles I Ann, Charles M Edwards, Cherrie A Zachary, Cheryl A Clausen, Chiaochun J Wang, Ching Jeyg Chang, Christian L Witkovskie, Christina Capacci Daniel, PhD, Christina L Bigham, Christine E Kelley, Claire M Minden, Courtney E Hillier, Craig P Seaborn, Craig T Rybus, Cynthia J Lee, MS, Cynthia T Cain, D Yvette Barnett, Daniel J Roberts, Darren S Brown, David Acevedo, David C Radle, David J Eide, David J Gomes, David M Beltran, David P Moorhead, David S Jackson, Dawn M Braswell, Deborah M Trout, Debra I Love, Dell S Moller, Diane R Mcdaniel, Djamila Harouaka, Doan T Nguyen, PharmD, Don H Bark, PhD, Dongping Dai, PhD, Donna F Campbell, Dorathy M Eischen, Douglas A Campbell, Douglas C Kovacs, Dr. Abhijit Raha, PhD, Dr. Chunchang Fang, Dr. Gang Wang, PhD, Dr. Guang Gao, PhD, Dr. Mark J Seaton, PhD, Dr. Robert C Horan, MD, Dr. Yubing Tang, Dr. Zhou Chen (nmi), MD PhD, Dyvette Arline, Edmund F Mrak, Jr, Elisa A Nickum, Elizabeth B Griffin, Elizabeth L Loreaux, Elizabeth Ll Edwards, Elizabeth P Kinsella, Emest F Bizjak, Erika V Butler, Erin D Mccaffery, Felix Maldonado, Frederick M Fochner, Frederick M Lochner, Gam S Zamil, Gayle S Lawson, Genevieve E Ghand, Geoffrey K Kilili, George J Flynn, Geraldine D Sanders, Geraldine Sanders, Green, Gretchen N Kilby, Gwyn G Dickinson, Harry J Brewer, Holly J Wilson, Hugh M Mcclure, II, Huiquan Wu, Isabel Y Espinosa, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, James C Maclaughlin, James G Marsh, James I Giefer, James L Dunnie, Jr, James L Finn, James M Mason, James Norman, James R Evans, Jamie L Dion, Jane L Chang, Janet L Bowen, Jason D Werne, Jason G Marsh, Javonica F Penn, Javonica Penn, Jawaid Hamid, Jazmine N Still, Jeffrey A Sincek, Jeffrey D Meng, Jeffrey P Raimondi, Jennifer A Pruden, Jennifer L Gustavus, Jennifer L Huntington, Jennifer L Jager, Jennifer L Sheehan, Jennifer L Watson, Jennifer M Heitz, Jerry J Corwin, Jessica M Novak, Jessica M Wooten, Jill R Loeliger, Jill R Raezer, Joel D Hustedt, John D Jaworski, John E Russell, John P Mistler, Jon P Antoniou, Jonathan A Ferguson, Jonathan W Chapman, Joohi Castelvetere, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose R Hernandez, Joseph A Piechocki, Joseph F Mcginnis, RPh, Joseph R Lambert, Joseph X Kaufman, Joshua P Wireman, Joshua S Hunt, Joshua Wireman, Joy Rkozlowski Klena, Julie D Bringger, Justin A Boyd, Kara D Dobbin, Karen M Cooper, Karen M Kondas, Karen Takahashi, Katherine Szestypalow, Kathleen D Culver, Kathleen Dant Ceckner, Kathryn E Ogger, Kathryn J Mccarty, Katie L Korchinski, Kelli Wilkinson, Kellia N Hicks, Kelsey M Griffin, Kenneth E Felkley, Kenneth H Williams, Kerry Ann Latham, Kevin A Gonzalez, Kevin D Kallander, Kevin Obrien, Kevin P Regan, Kham Phommachanh, Kim Lthomas Cruse, Klein, Krishna Ghosh, PhD, Krista T Ferry, Kristen D Evans, Laine P Myers, Laureen M Geniusz, Lauren N Howard, Lauren N Smith, Lauren R Collins, LCDR Chad N Thompson, Leena Thomas, Leonard H Lavi, Leslie R Clark, Li Li, Lianji Jin, Liming Zhang, Lindsey M Schwierjobann, Lindsey M Schwierjohann, Lisa Hornback, Lisa L Flores, Lisa R Hilliar, Lloyd D Payne, Logan T Williams, LTJG Matthew R Palo, Luckner Jean Marie, Luella J Rossi, Lydia Irosas Marty, Lynda L Perry, PhD, Lynnsey A Renn, Maney P Sturgill, Marcellinus D Dordunoo, Marcia A Worley, Marcus A Ray, Marianela Aponte Cruz, Marianne Allen, Maribeth G Grattan, Maribeth G Niesen, Marie F Morin, Marijo B Kambere, PhD, Marion Michaelis, Mark E Parmon, Mary B Sheets, Mary E Storch, Maryam Tabatabaie, Matt D Suedkamp, Matthew B Casale, Matthew H Pitts, Mei Chiung J Huang, Meisha R Sampson, Mekonnen Lemma Dechassa, PhD, Michael A Charles, Michael Campbell, Michael E Campbell, Michael E Clark, Michael I Gorman, Michael J Schibi, Michael K Larson, Michael P Sheehan, Michael R Goga, Michele Gottshall, Michele Perry Williams, Michelle L Jones, Mikhail V Ovanesov, PhD, Mpris Inspector, Mra Davism, Mra Mcculloughj, Muna Algharibeh, Nadeem I Chaudhry, Nancy L Neiger, Nicholas L Paulin, Nicholas Paulin, Nicole E Knowlton, Nina Ni, Nisha C Patel, Noreen Muniz, Omotunde O Osunsanmi, Pal S Mayasandra, Pamela A Kuist, Paranthaman Senthamaraikannan, Parul M Patel, Patricia A Borrusso, Patricia A Cochran, Patricia A Homola, Patricia H Dlugosz, Patrick C Klotzbuecher, Patrick W Mcafee, Paul A Bonneau, Paul L Bellamy, Paula A Trost, Payne, Penny H Mccarver, Peter E Baker, Philip S Woodward, Phillip M Pontikos, Pifer, Prabhu P Raju, Qin Xu, Rafael E Arroyo, Rafael Nevarez Nieves, Rafeeq A Habeeb, Ralph A Erickson, Ramesh Potla, PhD, Raquel Gonzalez, Raquel Gonzalez Rivera, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard H Penta, Richard T Riggie, Richard W Berning, Robert C Steyert, Robert D Tollefsen, Robert J Ham, Robert J Martin, Robert Rodriguez, Robert W Hudson, Robert W Jennings, Roger F Zabinski, Rosanna M Goodrich, Rose M Ashley, Rose Xu, Roy Baby, Roy C Stephens, Roy R Rinc, Rumany C Penn, PharmD, Said H Muse, Saleem A Akhtar, Samantha J Bradley, Samina S Khan, Samuel A Hamblin, Sandra A Hughes, Santos E Camara, Sarah E Rhoades, Satheesh Thomas, Scott N Lim, Scott T Ballard, Sena G Dissmeyer, Seneca D Toms, Shankar L Saha, Simone E Pitts, Skyler W Smith, Sneha S Patel, State Agency, Stephanie A Slater, MS, Stephen D Brown, Stephen J Kilker, Stephen J Rabe, Steven D Dittert, Steven E Bowen, PhD, Steven M Weinman, Steven P Eastham, Susan M Taylor, Susan O Oladeji, Susant Hadman, Sydney S Choi, Talmane J Fisher, Tamara M Kays, Tarun D Mehta, Ted L Anderson, Teresa I Navas, Teresa K Kastner, Theresa Kirkham (NMI), Thomas A Peter, Thomas C Woods, Thomas J Arista, Thomas J Prigge, Thomas S Arista, Thomas W Nojek, Thunder N Dunkijacobs, Timothy H Vo, Timothy T Kapsala, Tonia F Bernard, Torrance J Slayton, Torrey M Ward, Toyin B Oladimeji, Tracey L Harris, Tracy K Li, Travis R Hunt, Troy A Huffman, Truong Xuan Nguyen (Andy), Tyra S Wisecup, Ucheabuchi C Chudi Nwankwor, Uttaniti Limchumroon (Tom), Valerie M Steffens, Valerie M Toomey, Vilmary Negron Rodriguez, Vincent Thomas, Vipulchandra N Dholakia, Vlada Matusovsky, Wayne D Mcgrath, Wayne T Smith, Wen Ning Chan (Sally), William A Warnick, William K Ducloux, Xiaoping Guan, Xikui Chen (nmi), PhD, Yasamin Ameri, Yifan Wang, Ying Zhang, Yongming Lu, Yumi J Hiramine, Yvette Mlacour Davis, Zakaria I Ganiyu, Zhigang Sun, PhD, Zi Qiang Gu

Christopher T Middendorf's Documents

Publish Date Document Type Title
June, 2014 FDA 483 Response Ben Venue Laboratories Inc. - Form 483R, 2014-06-19
March, 2015 FDA 483 American Regent, Inc. - Form 483, 2015-03-19
March, 2018 FDA 483 Zhejiang Huazhou Pharmaceutical Co., Ltd. - Form 483, 2018-03-22
March, 2010 EIR Patheon Pharmaceuticals Inc. - EIR, 2010-03-24
March, 2013 EIR Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Helmut-Vetter-Strasse) - EIR, 2013-03-14
January, 2016 FDA 483 Zhejiang Jiuzhou Pharmaceutical Co., Ltd. - Form 483, 2016-01-23
August, 2017 FDA 483 WuXi Biologics Co., Ltd. - Form 483, 2017-08-02
November, 2010 FDA 483 Response Teva Women's Health LLC - Form 483R, 2010-11-30
June, 2014 EIR Ben Venue Laboratories Inc. - EIR, 2014-06-06
October, 2015 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2015-10-08
July, 2014 FDA 483 Resilience US, Inc. - Form 483, 2014-07-22
March, 2014 FDA 483 Terumo BCT Ltd - Form 483, 2014-03-28
March, 2019 FDA 483 Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) - Form 483, 2019-03-22
December, 2016 FDA 483 Shandong Zouping Dazhan New Materials Co., Ltd. - Form 483, 2016-12-08
January, 2014 FDA 483 N-Molecular Inc. dba SOFIE - Form 483, 2014-01-31
September, 2018 FDA 483 Changzhou Ruiming Pharmaceutical Co.,Ltd. - Form 483, 2018-09-25
August, 2011 FDA 483 BWXT Medical Ltd. - Form 483, 2011-08-31
April, 2009 EIR Caudill Sprouting LLC. - EIR, 2009-04-17
April, 2016 EIR Neogen Corporation - Mercer Rd. - EIR, 2016-04-28
July, 2012 FDA 483 Resilience US, Inc. - Form 483, 2012-07-11
June, 2010 EIR AlloSource Inc - EIR, 2010-06-25
July, 2012 EIR Resilience US, Inc. - EIR, 2012-07-11
September, 2017 FDA 483 Zhuhai United Laboratories Co., Ltd - Form 483, 2017-09-15
February, 2012 EIR Nitto Denko Avecia Inc. - EIR, 2012-02-17
April, 2019 EIR WuXi Biologics Co., Ltd. - EIR, 2019-04-16
September, 2012 FDA 483 Cardinal Health 414, LLC - Form 483, 2012-09-11
November, 2018 FDA 483 Hisun Pharmaceutical (Hangzhou) Co., Ltd. - Form 483, 2018-11-13
September, 2015 FDA 483 RXQ Compounding LLC - Form 483, 2015-09-21
November, 2010 EIR Teva Women's Health LLC - EIR, 2010-11-08
November, 2012 FDA 483 Allergan Sales, LLC - Form 483, 2012-11-05
July, 2014 FDA 483 Response Resilience US, Inc. - Form 483R, 2014-08-11
March, 2013 FDA 483 PEKANA Naturheilmittel GmbH - Form 483, 2013-03-08
November, 2010 FDA 483 Teva Women's Health LLC - Form 483, 2010-11-08
November, 2014 FDA 483 Attix Pharmaceuticals - Form 483, 2014-11-14
June, 2014 EIR Alza Corporation - EIR, 2014-06-05
August, 2017 FDA 483 CSPC Ouyi Pharmaceutical Co., Ltd. - Form 483, 2017-08-02
April, 2016 EIR Neogen Corporation - EIR, 2016-04-26
May, 2013 EIR PETNET SOLUTIONS, INC. - EIR, 2013-05-17
March, 2016 FDA 483 Patheon Pharmaceuticals Inc. - Form 483, 2016-03-11
January, 2018 FDA 483 Tianjin Weijie Pharmaceutical Co., Ltd. - Form 483, 2018-01-11
January, 2016 FDA 483 Tianjin Jingye Fine Chemicals Co., Ltd. - Form 483, 2016-01-15
November, 2017 FDA 483 Chongqing Carelife Pharmaceutical Co., Ltd. - Form 483, 2017-11-30
April, 2009 EIR Caudill Sprouting LLC. - EIR, 2009-04-29
August, 2018 FDA 483 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd - Form 483, 2018-08-23
October, 2019 FDA 483 Changzhou Pharmaceutical Factory - Form 483, 2019-10-18
March, 2010 FDA 483 Cincinnati Eye Bank for Sight Restoration LLC - Form 483, 2010-03-26
August, 2015 EIR West-Ward Columbus Inc. - EIR, 2015-08-14
July, 2014 EIR Resilience US, Inc. - EIR, 2014-07-22
November, 2016 FDA 483 Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - Form 483, 2016-11-02
June, 2014 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2014-06-06
August, 2014 FDA 483 American Regent, Inc. - Form 483, 2014-08-08
March, 2016 EIR Patheon Pharmaceuticals Inc. - EIR, 2016-03-11
December, 2011 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2011-12-02
March, 2018 FDA 483 Hisun Pharmaceutical (Hangzhou) Co., Ltd. - Form 483, 2018-03-06
April, 2019 FDA 483 WuXi Biologics Co., Ltd. - Form 483, 2019-04-16
November, 2012 EIR Allergan Sales, LLC - EIR, 2012-11-05
May, 2013 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2013-05-17
May, 2011 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2011-05-25

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more